Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Selegiline skin patch studied for smoking cessation

Jan. 12, 2007

Xytis signs CRADA for neboglamine in cocaine addiction

Jan. 9, 2007

Development plans updated for CPP-109 in drug addiction

Jan. 5, 2007

Outlicensing activities continue for CYT002-NicQb in nicotine addiction

Dec. 27, 2006

FDA approves Cyanokit for cyanide poisoning

Dec. 19, 2006

Novel CRH-R1 antagonist shows potential for the treatment of alcohol abuse

Dec. 19, 2006

Champix launched in U.K.

Dec. 4, 2006

Lundbeck and Biotie sign agreement for nalmefene

Nov. 29, 2006

New series of synthetic CLIP-derived peptides disclosed in recent patent

Nov. 27, 2006

Novel CYP2A inhibitors for smoking cessation patented by InflaZyme

Nov. 2, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.